Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport

Abstract Carriers of the APOE4 (apolipoprotein E ε4) variant of the APOE gene are subject to several age‐related health risks, including Alzheimer's disease (AD). The deficient lipid and cholesterol transport capabilities of the APOE4 protein are one reason for the altered risk profile. In particular, APOE4 carriers are at elevated risk for sporadic AD. While deposits o misfolded proteins are present in the AD brain, white matter (WM) myelin is also disturbed. As myelin is a lipid‐ and cholesterol‐rich structure, the connection to APOE makes considerable biological sense. To explore the APOE‐WM connection, we have analyzed the impact of human APOE4 on oligodendrocytes (OLs) of the mouse both in vivo and in vitro . We find that APOE proteins is enriched in astrocytes but sparse in OL. In human APOE4 (hAPOE4) knock‐in mice, myelin lipid content is increased but the density of major myelin proteins (MBP, MAG, and PLP) is largely unchanged. We also find an unexpected but significant reduction of cell density of the OL lineage (Olig2 + ) and an abnormal accumulation of OL precursors (Nkx 2.2 + ), suggesting a disruption of OL differentiation. Gene ontology analysis of an existing RNA‐seq dataset confirms a robust transcriptional response to the altered chemistry of the hAPOE4 mouse brain. In culture, the uptake of astrocyte‐derived APOE during Lovastatin‐mediated depletion of cholesterol synthesis is sufficient to sustain OL differentiation. While endogenous hAPOE protein isoforms have no effects on OL development, exogenous hAPOE4 abolishes the ability of very low‐density lipoprotein to restore myelination in Apoe ‐deficient, cholesterol‐depleted OL. Our data suggest that APOE4 impairs myelination in the aging brain by interrupting the delivery of astrocyte‐derived lipids to the oligodendrocytes. We propose that high myelin turnover and OL exhaustion found in APOE4 carriers is a likely explanation for the APOE‐dependent myelin phenotypes of the AD brain. image